Cargando…

Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis

BACKGROUND: Longdan Xiegan decoction (LDXGD) has been widely used in the treatment of eczema. In recent years, randomized controlled trials (RCTs) of LDXGD for the treatment of eczema have gradually increased. Most of the results show that LDXGD is effective in treating eczema. However, whether thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ziteng, Gao, Lidong, Li, Chengxian, Cucco, Alberto, Wang, Shang, Yuan, Weiling, Zhang, Fan, Kang, Shuai, Wang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906809/
https://www.ncbi.nlm.nih.gov/pubmed/33680065
http://dx.doi.org/10.1155/2021/8836117
_version_ 1783655367207550976
author Hu, Ziteng
Gao, Lidong
Li, Chengxian
Cucco, Alberto
Wang, Shang
Yuan, Weiling
Zhang, Fan
Kang, Shuai
Wang, Min
author_facet Hu, Ziteng
Gao, Lidong
Li, Chengxian
Cucco, Alberto
Wang, Shang
Yuan, Weiling
Zhang, Fan
Kang, Shuai
Wang, Min
author_sort Hu, Ziteng
collection PubMed
description BACKGROUND: Longdan Xiegan decoction (LDXGD) has been widely used in the treatment of eczema. In recent years, randomized controlled trials (RCTs) of LDXGD for the treatment of eczema have gradually increased. Most of the results show that LDXGD is effective in treating eczema. However, whether these conclusions are reliable or not requires meta-analysis. OBJECTIVE: This study aimed to systematically evaluate the clinical efficacy of LDXGD in the treatment of eczema. MATERIALS AND METHODS: Seven electronic databases, including PubMed, Excerpta Medica Database (EMBASE), Cochrane Library, Chinese Biomedical Literature on Disc (CBM), China National Knowledge Infrastructure (CNKI), WanFang, and Chinese Science and Technology Periodical Database (VIP) were systematically searched from their inception until January 2021. Risk of bias was assessed using criteria from the Cochrane Collaboration and meta-analysis was conducted on the screened literature data using Review Manage (RevMan 5.3). Then, to assess the quality of evidence, the GRADE criteria was adopted. RESULTS: 14 RCTs with 1080 participants were identified. Meta-analysis indicated that compared with western medicine (WM), the cure rate and the total effective rate of LDXGD in treating eczema were higher. Meanwhile, the recurrence rate and the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF-α) after treatment were lower. The adverse reaction was reported in 5 out of 14 studies without significant statistical difference. According to GRADE criteria, the quality of evidence was low for all outcomes except for the cure rate (moderate-quality evidence) and the total effective rate (moderate-quality evidence). CONCLUSION: The clinical efficacy of LDXGD in the treatment of eczema was more effective compared with the one of conventional WM alone. However, due to the limitation of the quality of the included studies, additional studies are required to further confirm these results.
format Online
Article
Text
id pubmed-7906809
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-79068092021-03-04 Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis Hu, Ziteng Gao, Lidong Li, Chengxian Cucco, Alberto Wang, Shang Yuan, Weiling Zhang, Fan Kang, Shuai Wang, Min Evid Based Complement Alternat Med Review Article BACKGROUND: Longdan Xiegan decoction (LDXGD) has been widely used in the treatment of eczema. In recent years, randomized controlled trials (RCTs) of LDXGD for the treatment of eczema have gradually increased. Most of the results show that LDXGD is effective in treating eczema. However, whether these conclusions are reliable or not requires meta-analysis. OBJECTIVE: This study aimed to systematically evaluate the clinical efficacy of LDXGD in the treatment of eczema. MATERIALS AND METHODS: Seven electronic databases, including PubMed, Excerpta Medica Database (EMBASE), Cochrane Library, Chinese Biomedical Literature on Disc (CBM), China National Knowledge Infrastructure (CNKI), WanFang, and Chinese Science and Technology Periodical Database (VIP) were systematically searched from their inception until January 2021. Risk of bias was assessed using criteria from the Cochrane Collaboration and meta-analysis was conducted on the screened literature data using Review Manage (RevMan 5.3). Then, to assess the quality of evidence, the GRADE criteria was adopted. RESULTS: 14 RCTs with 1080 participants were identified. Meta-analysis indicated that compared with western medicine (WM), the cure rate and the total effective rate of LDXGD in treating eczema were higher. Meanwhile, the recurrence rate and the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF-α) after treatment were lower. The adverse reaction was reported in 5 out of 14 studies without significant statistical difference. According to GRADE criteria, the quality of evidence was low for all outcomes except for the cure rate (moderate-quality evidence) and the total effective rate (moderate-quality evidence). CONCLUSION: The clinical efficacy of LDXGD in the treatment of eczema was more effective compared with the one of conventional WM alone. However, due to the limitation of the quality of the included studies, additional studies are required to further confirm these results. Hindawi 2021-02-18 /pmc/articles/PMC7906809/ /pubmed/33680065 http://dx.doi.org/10.1155/2021/8836117 Text en Copyright © 2021 Ziteng Hu et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Hu, Ziteng
Gao, Lidong
Li, Chengxian
Cucco, Alberto
Wang, Shang
Yuan, Weiling
Zhang, Fan
Kang, Shuai
Wang, Min
Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title_full Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title_fullStr Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title_full_unstemmed Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title_short Efficacy of Longdan Xiegan Decoction on the Treatment of Eczema: A Systematic Review and Meta-Analysis
title_sort efficacy of longdan xiegan decoction on the treatment of eczema: a systematic review and meta-analysis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906809/
https://www.ncbi.nlm.nih.gov/pubmed/33680065
http://dx.doi.org/10.1155/2021/8836117
work_keys_str_mv AT huziteng efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT gaolidong efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT lichengxian efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT cuccoalberto efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT wangshang efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT yuanweiling efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT zhangfan efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT kangshuai efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis
AT wangmin efficacyoflongdanxiegandecoctiononthetreatmentofeczemaasystematicreviewandmetaanalysis